Karyopharm Therapeutics reported $4.25M in Stock for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Amgen AMGN:US USD 4.93B 173M
GlaxoSmithKline GSK:LN GBP 5.15B 487M
Karyopharm Therapeutics KPTI:US USD 4.25M 779K
Macrogenics MGNX:US USD 1.09M 1.86M
Nektar Therapeutics NKTR:US USD 19.06M 2.09M
Novartis NOVN:VX USD 6.78B 101M
Regeneron Pharmaceuticals REGN:US USD 2.41B 193.7M
Roche Holding ROG:VX 8.29B 577M
Ultragenyx Pharmaceutical RARE:US USD 21.85M 770K
YTE INCY:US USD 45.87M 8.63M